Bringing extensive experience to the table, the fund manager has actively engaged in the healthcare sector, completing over 50 deals across North America and Europe. Their strategic style emphasizes a data-driven approach, enabling informed investment decisions from early-stage startups to mature companies. Notable exits include several high-performing biotech firms, showcasing their ability to identify and nurture transformative innovations. With a strong focus on thematic investments, they have built a diverse portfolio that addresses critical healthcare challenges.